MTB
52
3
SYY
48
-2
AAPL
59
-2
LNC
45
2
PPL
62
2
MPC
39
-2
DTE
45
3
SWKS
38
-15
AEP
42
3
AFL
62
5
ALL
53
3
LRCX
50
-3
AEE
45
4
GE
67
-3
LYB
37
-2
BXP
42
-5
RF
48
4
JCI
38
-12
CCL
33
-6
EA
68
6
MTB
52
3
SYY
48
-2
AAPL
59
-2
LNC
45
2
PPL
62
2
MPC
39
-2
DTE
45
3
SWKS
38
-15
AEP
42
3
AFL
62
5
ALL
53
3
LRCX
50
-3
AEE
45
4
GE
67
-3
LYB
37
-2
BXP
42
-5
RF
48
4
JCI
38
-12
CCL
33
-6
EA
68
6
Financhill
Back

Akero Therapeutics Stock Predictions

MarketBeat Alert: Strong sell signal just issued for these 20 stocks

Go here now to get free instant access to all 20 stocks to sell.
Sell
25

AKRO
Akero Therapeutics

Last Price:
20.13
Seasonality Move:
16.15%

7 Day Trial

ALL ACCESS PASS

$ 7

7 Powerhouse Stocks to Buy and Hold Forever

Get it now.

Akero Therapeutics Stock Forecast

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 70.2% based on the past 4 years of stock performance.
  • Akero Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Akero Therapeutics Stock Undervalued?
    The current Akero Therapeutics [AKRO] share price is $20.08. The Score for AKRO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Akero Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 70.2% based on the past 4 years of stock performance.

Akero Therapeutics Stock Rating

Sell
25
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics overpriced?

  • Akero Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Akero Therapeutics Stock Price History

Is AKRO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com

52-Week Data

52-Week High:
58.38
52-Week Low:
11.25

Prediction Charts

Market Cap:
1.38B
Price in USD:
20.08
Volume:
819.55K
Beta:
-0.29

Technical Analysis

SMA50:
24.49
SMA100:
23.13
SMA200:
28.44
52-Wk Change:
-55.31%

Stock Predictions

  • Is Akero Therapeutics stock public?
    Yes, Akero Therapeutics is a publicly traded company.
  • What is the Akero Therapeutics stock quote today?
    The Akero Therapeutics stock price is 20.08 USD today.
  • How to buy Akero Therapeutics stock online?
    You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-12 21.89 22.19 22.22 21.36
Apr-15 22.29 21.79 22.40 21.49
Apr-16 21.58 21.79 22.06 21.38
Apr-17 21.88 21.60 22.18 21.57
Apr-18 21.41 20.53 21.46 20.42
Apr-19 20.44 20.74 21.05 20.39
Apr-22 20.80 20.79 21.02 19.89
Apr-23 20.94 21.00 21.23 20.74
Apr-24 20.95 20.26 21.51 20.12
Apr-25 19.99 18.93 19.99 18.20
Apr-26 19.18 19.74 19.97 18.95
Apr-29 19.64 19.62 20.02 19.31
Apr-30 19.99 19.89 20.33 19.33
May-1 20.00 20.08 20.64 19.72

Akero Therapeutics Earnings

Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Akero Therapeutics Forecast Revenue Growth

Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.

* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.